Longer-term Study of AR101 in Subjects Who Participated in a Prior AR101 Study (ARC008)
Clinical trial NCT03292484 · COMPLETED
Trial details
- NCT number
- NCT03292484
- Sponsor
- Aimmune Therapeutics, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-11-02
- Primary completion
- 2023-04-27
- Enrollment
- 911
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.